Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy. - Long, Junyu; Yang, Xu; Bian, Jin; Wang, Dongxu; Wang, Anqiang; Lin, Yu; Zheng, Mingjun; Zhang, Haohai; Sang, Xinting; Zhao, Haitao (Clinical & Translational Medicine, 2021)